A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication.
暂无分享,去创建一个
A. Capron | G. Bahr | Y. Mouton | E. Darcissac | M. Truong | V. Delsart | C. Cocude | O. Billaut‐Mulot
[1] A. Rice,et al. Transient Induction of Cyclin T1 during Human Macrophage Differentiation Regulates Human Immunodeficiency Virus Type 1 Tat Transactivation Function , 2002, Journal of Virology.
[2] G. Bahr,et al. Clinical Tolerance and Immunologic Effects After Single or Repeated Administrations of the Synthetic Immunomodulator Murabutide in HIV‐1‐Infected Patients , 2002 .
[3] F. Martinon,et al. Overexpression of Helicard, a CARD-Containing Helicase Cleaved during Apoptosis, Accelerates DNA Degradation , 2002, Current Biology.
[4] Wendy A Bickmore,et al. Addressing protein localization within the nucleus , 2002, The EMBO journal.
[5] E. Olson,et al. Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] Paul B. Fisher,et al. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Capron,et al. SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus. , 2001, The Journal of clinical investigation.
[8] G. Bahr,et al. Selective Regulation of Human Immunodeficiency Virus-Infected CD4+ Lymphocytes by a Synthetic Immunomodulator Leads to Potent Virus Suppression In Vitro and in hu-PBL-SCID Mice , 2001, Journal of Virology.
[9] A. Capron,et al. Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost. , 2001, Vaccine.
[10] J. Angel. Improving immune function and controlling viral replication in HIV-1-infected patients with immune-based therapies. , 2001, The AIDS reader.
[11] C. Martínez-A,et al. Cell-cycle regulation in immunity, tolerance and autoimmunity. , 2000, Immunology today.
[12] G. Bahr,et al. The Synthetic Immunomodulator Murabutide Controls Human Immunodeficiency Virus Type 1 Replication at Multiple Levels in Macrophages and Dendritic Cells , 2000, Journal of Virology.
[13] F. Wong-Staal,et al. Sam68, RNA helicase A and Tap cooperate in the post-transcriptional regulation of human immunodeficiency virus and type D retroviral mRNA , 2000, Oncogene.
[14] M. Kazatchkine,et al. High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy. , 2000, The Journal of infectious diseases.
[15] L. Schook,et al. An RNA helicase, RHIV -1, induced by porcine reproductive and respiratory syndrome virus (PRRSV) is mapped on porcine chromosome 10q13. , 2000, Microbial pathogenesis.
[16] Y. Cao,et al. HIV-1 drug resistance in newly infected individuals. , 1999, JAMA.
[17] G. Bahr,et al. Interleukin-16 Inhibits Human Immunodeficiency Virus Type 1 Entry and Replication in Macrophages and in Dendritic Cells , 1999, Journal of Virology.
[18] D. Hazuda,et al. Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] H. Worman,et al. Hepatitis C Virus Core Protein Binds to a DEAD Box RNA Helicase* , 1999, The Journal of Biological Chemistry.
[20] É. Cohen,et al. Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Functions as an Immediate-Early Protein during HIV-1 Infection , 1999, Journal of Virology.
[21] Chi-Hung Lin,et al. Hepatitis C Virus Core Protein Interacts with Cellular Putative RNA Helicase , 1999, Journal of Virology.
[22] D. Rose,et al. A role for RNA helicase A in post-transcriptional regulation of HIV type 1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Roebuck,et al. Human immunodeficiency virus type-1 transcription: role of the 5'-untranslated leader region (review). , 1998, International journal of molecular medicine.
[24] D. Baltimore,et al. HIV-1 Directly Kills CD4+ T Cells by a Fas-independent Mechanism , 1998, The Journal of experimental medicine.
[25] D. Mosier,et al. Apoptosis induced by HIV infection in H9 T cells is blocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist. , 1996, Journal of immunology.
[26] L. Chedid,et al. Immunopharmacological activities and clinical development of muramyl peptides with particular emphasis on murabutide. , 1995, International journal of immunopharmacology.
[27] G. Pavlakis,et al. Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction. , 1994, AIDS research and human retroviruses.
[28] L. Chedid,et al. Prophylactic and therapeutic effects of murabutide in OF1 mice infected with influenza A/H3N2 (A/Texas/1/77) virus. , 1988, Journal of biological response modifiers.
[29] E. Lederer,et al. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity , 1982, Infection and immunity.
[30] G. Bahr. Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide. , 2003, The Journal of antimicrobial chemotherapy.
[31] G. Bahr,et al. Clinical tolerance and immunologic effects after single or repeated administrations of the synthetic immunomodulator murabutide in HIV-1-infected patients. , 2002, Journal of acquired immune deficiency syndromes.
[32] Eckhard Jankowsky,et al. The DExH/D protein family database , 2000, Nucleic Acids Res..
[33] M. Lederman,et al. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. , 2000, The Journal of infectious diseases.
[34] A. Capron,et al. Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression. , 1999, The Journal of infectious diseases.
[35] U. Stahl,et al. The protein family of RNA helicases. , 1998, Critical reviews in biochemistry and molecular biology.
[36] D O Morgan,et al. Cyclin-dependent kinases: engines, clocks, and microprocessors. , 1997, Annual review of cell and developmental biology.
[37] Gapped BLAST and PSI-BLAST: A new , 1997 .
[38] J. Lifson,et al. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. , 1993, BioTechniques.